The U.S. Food and Drug Administration sent warning letters to four drug companies, saying their promotional materials for four drugs make inaccurate or incomplete statements. The FDA demanded that Bayer, Eli Lilly (LLY), Cephalon (CEPH) and Amylin Pharmaceuticals (AMLN) stop using ads the agency says exaggerate the efficacy of a drug or downplay its risks.
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
Why Your 2012 Tax Bill May Jump By $8,000
Savings Experiment: Tissues vs. Toilet Paper
Savings Experiment: Snow Removal
Why the U.S. Should Get Rid of the $1 Bill
